Cargando...

Similar Durability of Two Single Tablet Regimens, Dolutegravir/Abacavir/Lamivudine and Elvitegravir/Cobicistat/Tenofovir/Emtricitabine: Single Center Experience

Integrase inhibitor is uniquely available as single tablet regimen (STR) in Korea. In this study, the durability until 96 weeks was compared between dolutegravir/abacavir/lamivudine (D/A/L) and elvitegravir/cobicistat/tenofovir/emtricitabine (E/T/E) in treatment naïve human immunodeficiency virus 1...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Korean Med Sci
Main Authors: Chin, Bum Sik, Lee, Jin-Hee, Kim, Gayeon
Formato: Artigo
Idioma:Inglês
Publicado: The Korean Academy of Medical Sciences 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7384898/
https://ncbi.nlm.nih.gov/pubmed/32715668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2020.35.e235
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!